2m 2m 2m 2m 2m 2m 2m
JANUX THERAPEUTS (JANX)
NASDAQ
$17.45+$0.35 (+2.06%)
Price as of Sep 11, 2026 7:45 PM EDT- $1.0BMarket Cap
- -28.90%1-Year Change
- BiotechnologyIndustry
JANUX THERAPEUTS (JANX)
$17.45+$0.35 (+2.06%)
JANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.10 | ||
Change | -$0.58 (-3.28%) | ||
Open | $17.92 | ||
High | $17.94 | ||
Low | $17.05 | ||
Previous Close | $17.68 | ||
Volume | 791,602 | ||
30-Day Average Volume | 859,239 | ||
1-Week Change | -15.51% | ||
1-Month Change | 3.51% | ||
1-Year Change | -28.90% | ||
3-Year Change | 59.37% | ||
5-Year Change | -38.31% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $1.0B | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $10.3M | ||
Net Income | -$22.0M | ||
Free Cash Flow | $12.3M | ||
EBIT | -$22.0M | ||
EBITDA | -$21.5M | ||
Net Working Capital | $923.2M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 99 | ||
P/B | 1 | ||
P/E | -49 | ||
PEG | -5 | ||
Price/Free Cash Flow | 85 | ||
Price/Operating Cash Flow | 84 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue